APO Research
Talk to an analyst

APO RESEARCH · REPORT

Promethazine Hydrochloride Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Promethazine Hydrochloride Injection Market Outlook and Growth Opportunities 2026

21 December 2025195 pages

Choose your research edition.

Industry ResearchPromethazine Hydrochloride Injection Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Promethazine Hydrochloride Injection Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Promethazine Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Promethazine Hydrochloride Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Promethazine Hydrochloride Injection Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Promethazine Hydrochloride Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Promethazine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Promethazine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Promethazine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Promethazine Hydrochloride Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Promethazine Hydrochloride Injection market include Southwest Pharmaceutical, Tianjin Jinyao Group, Shanghai Shyndec Pharmaceutical, Shanghai Harvest Pharmaceutical, Sanofi, Jinling Pharmaceutical, Jilin Centennium Hanke Pharmacy, Pfizer and Hunan Hansen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Promethazine Hydrochloride Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Promethazine Hydrochloride Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Promethazine Hydrochloride Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Promethazine Hydrochloride Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Promethazine Hydrochloride Injection Segment by Company

Southwest Pharmaceutical

Tianjin Jinyao Group

Shanghai Shyndec Pharmaceutical

Shanghai Harvest Pharmaceutical

Sanofi

Jinling Pharmaceutical

Jilin Centennium Hanke Pharmacy

Pfizer

Hunan Hansen

Guangdong Southland Pharmaceutical

Hikma Pharmaceuticals

Advacare Pharma

Promethazine Hydrochloride Injection Segment by Type

Intravenous Drip

Intramuscular Injection

Promethazine Hydrochloride Injection Segment by Application

Hospital

Clinics

Other

Promethazine Hydrochloride Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Promethazine Hydrochloride Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Promethazine Hydrochloride Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Promethazine Hydrochloride Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Promethazine Hydrochloride Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Promethazine Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Promethazine Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Promethazine Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Promethazine Hydrochloride Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Promethazine Hydrochloride Injection industry.

Chapter 3: Detailed analysis of Promethazine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Promethazine Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Promethazine Hydrochloride Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Promethazine Hydrochloride Injection Industry Trends Table 2. Promethazine Hydrochloride Injection Industry Drivers Table 3. Promethazine Hydrochloride Injection Industry Opportunities and Challenges Table 4. Promethazine Hydrochloride Injection Industry Restraints Table 5. Global Promethazine Hydrochloride Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Promethazine Hydrochloride Injection Revenue Share by Company (2021-2026) Table 7. Global Promethazine Hydrochloride Injection Sales Volume by Company (k units) & (2021-2026) Table 8. Global Promethazine Hydrochloride Injection Sales Volume Share by Company (2021-2026) Table 9. Global Promethazine Hydrochloride Injection Average Price (US$/unit) of Company (2021-2026) Table 10. Global Promethazine Hydrochloride Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Promethazine Hydrochloride Injection Key Company Manufacturing Base & Headquarters Table 12. Global Promethazine Hydrochloride Injection Company, Product Type & Application Table 13. Global Promethazine Hydrochloride Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Promethazine Hydrochloride Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Intravenous Drip Table 18. Significant Companies of Intramuscular Injection Table 19. Global Promethazine Hydrochloride Injection Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Promethazine Hydrochloride Injection Sales Volume by Type (2021-2026) & (k units) Table 21. Global Promethazine Hydrochloride Injection Sales Volume by Type (2027-2032) & (k units) Table 22. Global Promethazine Hydrochloride Injection Sales Volume Share by Type (2021-2026) Table 23. Global Promethazine Hydrochloride Injection Sales Volume Share by Type (2027-2032) Table 24. Global Promethazine Hydrochloride Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Promethazine Hydrochloride Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Promethazine Hydrochloride Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Promethazine Hydrochloride Injection Sales Value Share by Type (2021-2026) Table 28. Global Promethazine Hydrochloride Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinics Table 31. Significant Companies of Other Table 32. Global Promethazine Hydrochloride Injection Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Promethazine Hydrochloride Injection Sales Volume by Application (2021-2026) & (k units) Table 34. Global Promethazine Hydrochloride Injection Sales Volume by Application (2027-2032) & (k units) Table 35. Global Promethazine Hydrochloride Injection Sales Volume Share by Application (2021-2026) Table 36. Global Promethazine Hydrochloride Injection Sales Volume Share by Application (2027-2032) Table 37. Global Promethazine Hydrochloride Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Promethazine Hydrochloride Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Promethazine Hydrochloride Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Promethazine Hydrochloride Injection Sales Value Share by Application (2021-2026) Table 41. Global Promethazine Hydrochloride Injection Sales Value Share by Application (2027-2032) Table 42. Global Promethazine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Promethazine Hydrochloride Injection Sales by Region (2021-2026) & (k units) Table 44. Global Promethazine Hydrochloride Injection Sales Market Share by Region (2021-2026) Table 45. Global Promethazine Hydrochloride Injection Sales by Region (2027-2032) & (k units) Table 46. Global Promethazine Hydrochloride Injection Sales Market Share by Region (2027-2032) Table 47. Global Promethazine Hydrochloride Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Promethazine Hydrochloride Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Promethazine Hydrochloride Injection Sales Value Share by Region (2021-2026) Table 50. Global Promethazine Hydrochloride Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Promethazine Hydrochloride Injection Sales Value Share by Region (2027-2032) Table 52. Global Promethazine Hydrochloride Injection Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Promethazine Hydrochloride Injection Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Promethazine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Promethazine Hydrochloride Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Promethazine Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 57. Global Promethazine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 58. Global Promethazine Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 59. Global Promethazine Hydrochloride Injection Sales Market Share by Country (2027-2032) Table 60. Global Promethazine Hydrochloride Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Promethazine Hydrochloride Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Promethazine Hydrochloride Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Promethazine Hydrochloride Injection Sales Value Market Share by Country (2027-2032) Table 64. Southwest Pharmaceutical Company Information Table 65. Southwest Pharmaceutical Business Overview Table 66. Southwest Pharmaceutical Promethazine Hydrochloride Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Southwest Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio Table 68. Southwest Pharmaceutical Recent Development Table 69. Tianjin Jinyao Group Company Information Table 70. Tianjin Jinyao Group Business Overview Table 71. Tianjin Jinyao Group Promethazine Hydrochloride Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Tianjin Jinyao Group Promethazine Hydrochloride Injection Product Portfolio Table 73. Tianjin Jinyao Group Recent Development Table 74. Shanghai Shyndec Pharmaceutical Company Information Table 75. Shanghai Shyndec Pharmaceutical Business Overview Table 76. Shanghai Shyndec Pharmaceutical Promethazine Hydrochloride Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Shanghai Shyndec Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio Table 78. Shanghai Shyndec Pharmaceutical Recent Development Table 79. Shanghai Harvest Pharmaceutical Company Information Table 80. Shanghai Harvest Pharmaceutical Business Overview Table 81. Shanghai Harvest Pharmaceutical Promethazine Hydrochloride Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Shanghai Harvest Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio Table 83. Shanghai Harvest Pharmaceutical Recent Development Table 84. Sanofi Company Information Table 85. Sanofi Business Overview Table 86. Sanofi Promethazine Hydrochloride Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Sanofi Promethazine Hydrochloride Injection Product Portfolio Table 88. Sanofi Recent Development Table 89. Jinling Pharmaceutical Company Information Table 90. Jinling Pharmaceutical Business Overview Table 91. Jinling Pharmaceutical Promethazine Hydrochloride Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Jinling Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio Table 93. Jinling Pharmaceutical Recent Development Table 94. Jilin Centennium Hanke Pharmacy Company Information Table 95. Jilin Centennium Hanke Pharmacy Business Overview Table 96. Jilin Centennium Hanke Pharmacy Promethazine Hydrochloride Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Jilin Centennium Hanke Pharmacy Promethazine Hydrochloride Injection Product Portfolio Table 98. Jilin Centennium Hanke Pharmacy Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Promethazine Hydrochloride Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Pfizer Promethazine Hydrochloride Injection Product Portfolio Table 103. Pfizer Recent Development Table 104. Hunan Hansen Company Information Table 105. Hunan Hansen Business Overview Table 106. Hunan Hansen Promethazine Hydrochloride Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Hunan Hansen Promethazine Hydrochloride Injection Product Portfolio Table 108. Hunan Hansen Recent Development Table 109. Guangdong Southland Pharmaceutical Company Information Table 110. Guangdong Southland Pharmaceutical Business Overview Table 111. Guangdong Southland Pharmaceutical Promethazine Hydrochloride Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Guangdong Southland Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio Table 113. Guangdong Southland Pharmaceutical Recent Development Table 114. Hikma Pharmaceuticals Company Information Table 115. Hikma Pharmaceuticals Business Overview Table 116. Hikma Pharmaceuticals Promethazine Hydrochloride Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Hikma Pharmaceuticals Promethazine Hydrochloride Injection Product Portfolio Table 118. Hikma Pharmaceuticals Recent Development Table 119. Advacare Pharma Company Information Table 120. Advacare Pharma Business Overview Table 121. Advacare Pharma Promethazine Hydrochloride Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Advacare Pharma Promethazine Hydrochloride Injection Product Portfolio Table 123. Advacare Pharma Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Promethazine Hydrochloride Injection Distributors List Table 127. Promethazine Hydrochloride Injection Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Promethazine Hydrochloride Injection Product Image Figure 2. Global Promethazine Hydrochloride Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Promethazine Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Promethazine Hydrochloride Injection Sales (2021-2032) & (k units) Figure 5. Global Promethazine Hydrochloride Injection Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Promethazine Hydrochloride Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Intravenous Drip Image Figure 10. Intramuscular Injection Image Figure 11. Global Promethazine Hydrochloride Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Promethazine Hydrochloride Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Promethazine Hydrochloride Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Promethazine Hydrochloride Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Promethazine Hydrochloride Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Promethazine Hydrochloride Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinics Image Figure 19. Other Image Figure 20. Global Promethazine Hydrochloride Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Promethazine Hydrochloride Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Promethazine Hydrochloride Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Promethazine Hydrochloride Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Promethazine Hydrochloride Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Promethazine Hydrochloride Injection Sales Value Share by Application (2021-2032) Figure 26. Global Promethazine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Promethazine Hydrochloride Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Promethazine Hydrochloride Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Promethazine Hydrochloride Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Promethazine Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Promethazine Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Promethazine Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Promethazine Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Promethazine Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Promethazine Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Promethazine Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Promethazine Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Promethazine Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Promethazine Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Promethazine Hydrochloride Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Promethazine Hydrochloride Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous Drip
  • Intramuscular Injection
Applications
  • Hospital
  • Clinics
  • Other
Companies covered
  • Southwest Pharmaceutical
  • Tianjin Jinyao Group
  • Shanghai Shyndec Pharmaceutical
  • Shanghai Harvest Pharmaceutical
  • Sanofi
  • Jinling Pharmaceutical
  • Jilin Centennium Hanke Pharmacy
  • Pfizer
  • Hunan Hansen
  • Guangdong Southland Pharmaceutical
  • Hikma Pharmaceuticals
  • Advacare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Promethazine Hydrochloride Injection Sales Value (2021-2032)
  4. 1.2.2 Global Promethazine Hydrochloride Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Promethazine Hydrochloride Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Promethazine Hydrochloride Injection Market Dynamics
  1. 2.1 Promethazine Hydrochloride Injection Industry Trends
  2. 2.2 Promethazine Hydrochloride Injection Industry Drivers
  3. 2.3 Promethazine Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Promethazine Hydrochloride Injection Industry Restraints
3 Promethazine Hydrochloride Injection Market by Company
  1. 3.1 Global Promethazine Hydrochloride Injection Company Revenue Ranking in 2025
  2. 3.2 Global Promethazine Hydrochloride Injection Revenue by Company (2021-2026)
  3. 3.3 Global Promethazine Hydrochloride Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Promethazine Hydrochloride Injection Average Price by Company (2021-2026)
  5. 3.5 Global Promethazine Hydrochloride Injection Company Ranking (2024-2026)
  6. 3.6 Global Promethazine Hydrochloride Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Promethazine Hydrochloride Injection Company Product Type and Application
  8. 3.8 Global Promethazine Hydrochloride Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Promethazine Hydrochloride Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Promethazine Hydrochloride Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Promethazine Hydrochloride Injection Market by Type
  1. 4.1 Promethazine Hydrochloride Injection Type Introduction
  2. 4.1.1 Intravenous Drip
  3. 4.1.2 Intramuscular Injection
  4. 4.2 Global Promethazine Hydrochloride Injection Sales Volume by Type
  5. 4.2.1 Global Promethazine Hydrochloride Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Promethazine Hydrochloride Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Promethazine Hydrochloride Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Promethazine Hydrochloride Injection Sales Value by Type
  9. 4.3.1 Global Promethazine Hydrochloride Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Promethazine Hydrochloride Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Promethazine Hydrochloride Injection Sales Value Share by Type (2021-2032)
5 Promethazine Hydrochloride Injection Market by Application
  1. 5.1 Promethazine Hydrochloride Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Promethazine Hydrochloride Injection Sales Volume by Application
  6. 5.2.1 Global Promethazine Hydrochloride Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Promethazine Hydrochloride Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Promethazine Hydrochloride Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Promethazine Hydrochloride Injection Sales Value by Application
  10. 5.3.1 Global Promethazine Hydrochloride Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Promethazine Hydrochloride Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Promethazine Hydrochloride Injection Sales Value Share by Application (2021-2032)
6 Promethazine Hydrochloride Injection Regional Sales and Value Analysis
  1. 6.1 Global Promethazine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Promethazine Hydrochloride Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Promethazine Hydrochloride Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Promethazine Hydrochloride Injection Sales by Region (2027-2032)
  5. 6.3 Global Promethazine Hydrochloride Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Promethazine Hydrochloride Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Promethazine Hydrochloride Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Promethazine Hydrochloride Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Promethazine Hydrochloride Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Promethazine Hydrochloride Injection Sales Value (2021-2032)
  12. 6.6.2 North America Promethazine Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Promethazine Hydrochloride Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Promethazine Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Promethazine Hydrochloride Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Promethazine Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Promethazine Hydrochloride Injection Sales Value (2021-2032)
  21. 6.9.2 South America Promethazine Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Promethazine Hydrochloride Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Promethazine Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
7 Promethazine Hydrochloride Injection Country-level Sales and Value Analysis
  1. 7.1 Global Promethazine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Promethazine Hydrochloride Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Promethazine Hydrochloride Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Promethazine Hydrochloride Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Promethazine Hydrochloride Injection Sales by Country (2027-2032)
  6. 7.4 Global Promethazine Hydrochloride Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Promethazine Hydrochloride Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Promethazine Hydrochloride Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Promethazine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Promethazine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Promethazine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Southwest Pharmaceutical
  2. 8.1.1 Southwest Pharmaceutical Company Information
  3. 8.1.2 Southwest Pharmaceutical Business Overview
  4. 8.1.3 Southwest Pharmaceutical Promethazine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Southwest Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
  6. 8.1.5 Southwest Pharmaceutical Recent Developments
  7. 8.2 Tianjin Jinyao Group
  8. 8.2.1 Tianjin Jinyao Group Company Information
  9. 8.2.2 Tianjin Jinyao Group Business Overview
  10. 8.2.3 Tianjin Jinyao Group Promethazine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tianjin Jinyao Group Promethazine Hydrochloride Injection Product Portfolio
  12. 8.2.5 Tianjin Jinyao Group Recent Developments
  13. 8.3 Shanghai Shyndec Pharmaceutical
  14. 8.3.1 Shanghai Shyndec Pharmaceutical Company Information
  15. 8.3.2 Shanghai Shyndec Pharmaceutical Business Overview
  16. 8.3.3 Shanghai Shyndec Pharmaceutical Promethazine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Shyndec Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
  18. 8.3.5 Shanghai Shyndec Pharmaceutical Recent Developments
  19. 8.4 Shanghai Harvest Pharmaceutical
  20. 8.4.1 Shanghai Harvest Pharmaceutical Company Information
  21. 8.4.2 Shanghai Harvest Pharmaceutical Business Overview
  22. 8.4.3 Shanghai Harvest Pharmaceutical Promethazine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Harvest Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
  24. 8.4.5 Shanghai Harvest Pharmaceutical Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi Promethazine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Promethazine Hydrochloride Injection Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Jinling Pharmaceutical
  32. 8.6.1 Jinling Pharmaceutical Company Information
  33. 8.6.2 Jinling Pharmaceutical Business Overview
  34. 8.6.3 Jinling Pharmaceutical Promethazine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jinling Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
  36. 8.6.5 Jinling Pharmaceutical Recent Developments
  37. 8.7 Jilin Centennium Hanke Pharmacy
  38. 8.7.1 Jilin Centennium Hanke Pharmacy Company Information
  39. 8.7.2 Jilin Centennium Hanke Pharmacy Business Overview
  40. 8.7.3 Jilin Centennium Hanke Pharmacy Promethazine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jilin Centennium Hanke Pharmacy Promethazine Hydrochloride Injection Product Portfolio
  42. 8.7.5 Jilin Centennium Hanke Pharmacy Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Promethazine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Promethazine Hydrochloride Injection Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Hunan Hansen
  50. 8.9.1 Hunan Hansen Company Information
  51. 8.9.2 Hunan Hansen Business Overview
  52. 8.9.3 Hunan Hansen Promethazine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hunan Hansen Promethazine Hydrochloride Injection Product Portfolio
  54. 8.9.5 Hunan Hansen Recent Developments
  55. 8.10 Guangdong Southland Pharmaceutical
  56. 8.10.1 Guangdong Southland Pharmaceutical Company Information
  57. 8.10.2 Guangdong Southland Pharmaceutical Business Overview
  58. 8.10.3 Guangdong Southland Pharmaceutical Promethazine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Guangdong Southland Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
  60. 8.10.5 Guangdong Southland Pharmaceutical Recent Developments
  61. 8.11 Hikma Pharmaceuticals
  62. 8.11.1 Hikma Pharmaceuticals Company Information
  63. 8.11.2 Hikma Pharmaceuticals Business Overview
  64. 8.11.3 Hikma Pharmaceuticals Promethazine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hikma Pharmaceuticals Promethazine Hydrochloride Injection Product Portfolio
  66. 8.11.5 Hikma Pharmaceuticals Recent Developments
  67. 8.12 Advacare Pharma
  68. 8.12.1 Advacare Pharma Company Information
  69. 8.12.2 Advacare Pharma Business Overview
  70. 8.12.3 Advacare Pharma Promethazine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Advacare Pharma Promethazine Hydrochloride Injection Product Portfolio
  72. 8.12.5 Advacare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Promethazine Hydrochloride Injection Value Chain Analysis
  2. 9.1.1 Promethazine Hydrochloride Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Promethazine Hydrochloride Injection Sales Mode & Process
  6. 9.2 Promethazine Hydrochloride Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Promethazine Hydrochloride Injection Distributors
  9. 9.2.3 Promethazine Hydrochloride Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst